Skip to content

Study on the central mechanism of acupuncture for uremic pruritus in hemodialysis patients with end-stage renal disease based on fNIRS

Evidence-based evaluation and central mechanism exploration of acupuncture for uremic pruritus in hemodialysis patients with end-stage renal disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001844
Enrollment
Unknown
Registered
2025-09-26
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uremic pruritus

Interventions

Acupuncture group:Acupuncture
Waiting-list group:non

Sponsors

Third Affiliated Hospital of Chengdu University of Traditional Chinese Medicine/Chengdu Pidu District Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Right-handed, 18 years old = age = 65 years old; (2) Meets the diagnostic criteria for end-stage renal disease and is accompanied by persistent itching symptoms for 6 weeks or more; (3) Has been regularly undergoing hemodialysis or hemofiltration treatment for more than 3 months; (4) The degree of itching is moderate to severe (average weekly score of 24-hour WI-NRS in the past week = 4 points, total score 10 points); (5) Within the first 3 months before enrollment, at least one single chamber urea clearance rate (spKt/V) of = 1.2 and urea decline rate (URR) of = 65%; (6) Not combined with serious mental illness or cognitive impairment; (7) Not combined with neurological diseases such as cerebral hemorrhage and cerebral infarction; (8) No addiction to alcohol or drugs; (9) Voluntarily participate in the research and provide written informed consent. Note: Only those who meet the above 9 criteria can be included.

Exclusion criteria

Exclusion criteria: (1) Patients with other skin diseases that can cause itching, such as psoriasis, atopic dermatitis, urticaria, contact dermatitis, etc; (2) Suffering from any severe chronic liver disease, or any one of alanine aminotransferase, aspartate aminotransferase, glutamyltransferase, or total bilirubin exceeding twice the upper limit of normal values; (3) Patients with malignant tumors or other serious illnesses that require hospitalization; (4) Individuals with severe mental illness or cognitive impairment (such as dementia); (5) During the research period, those who plan to undergo kidney transplantation or change their dialysis regimen to peritoneal dialysis; (6) Only those who experience itching during dialysis; (7) Individuals who have undergone physical therapy such as acupoint pressing, acupuncture, moxibustion, and phototherapy within one month to address itching symptoms; (8) Patients with coagulation dysfunction or local skin ulceration caused by acupuncture; (9) Individuals who have participated in another clinical study within the past six months and have been assessed by the researchers as potentially interfering with the evaluation of the results of this study, or who plan to participate in another clinical research during their participation in this study; (10) Pregnant or lactating women. Note: If any of the above conditions are met, it will be excluded.

Design outcomes

Primary

MeasureTime frame
Weekly average of 24-hour Worst Itch Numeric Rating Scale (24-hour WI-NRS);Cerebral functional network activity based on functional near-infrared spectroscopy(fNIRS);

Secondary

MeasureTime frame
14-item uremic pruritus in dialysis patients scale;Dermatology Life Quality Index;General anxiety disorder;Patient Health Questionnaire-9;

Countries

China

Contacts

Public ContactJie Chen

Third Affiliated Hospital of Chengdu University of Traditional Chinese Medicine/Chengdu Pidu District Traditional Chinese Medicine Hospital

1139051921@qq.com13982083001

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026